Oral Abstract Session:
216. HCV Advances
Saturday, October 29, 2016: 10:30 AM-12:00 PM
Room: 388-390

Learning Objectives:

.

Tracks: Adult ID

Moderators:  Ravi Jhaveri, MD, FIDSA, FPIDS, University of North Carolina and David Thomas, MD, MPH, FIDSA, Johns Hopkins University School of Medicine

Presentations:
10:30 AM
1785
Sofosbuvir/Velpatasvir Plus GS-9857(100MG) for 6, 8, or 12 Weeks in Genotype 1-6 HCV-Infected Patients: An Integrated Analysis of Safety and Efficacy from Two Phase 2 Studies
Ronald Nahass, MD, FIDSA, FSHEA ; Eric Lawitz, MD ; Ira M. Jacobson, MD ; Paul Kwo, MD ; Mindie Ngyuyen, MD ; Jenny C. Yang, PharmD ; Luisa Stamm, MD, PhD ; Sophia Lu, PhD ; Hadas Sobol, PhD ; Sarjita Naik, PharmD ; Joe Llewellyn, PharmD ; Diana Brainard, MD ; John G. Mchutchison, MD ; Michael Curry, MD ; Kris Kowdley, MD ; Nancy Reau, MD, FAASLD, AGAF ; Edward Gane, MD
10:43 AM
1786
The cost-effectiveness of hepatitis C screening strategies among adolescents and young adults in primary care settings
Sabrina Assoumou, MD, MPH ; Abriana Tasillo, BA ; Jared a. Leff, MS ; Bruce R. Shackman, PhD ; Mari-Lynn Drainoni, MEd, PhD ; C. Robert Horsburgh, MD MUS ; Anita Barry, MD, MPH ; Craig Regis, MPH ; Arthur Kim, MD, FIDSA ; Alison Marshall, RN, MSN, FNP-C ; Sheel Saxena, MD ; Benjamin Linas, MD, MPH
10:56 AM
1787
Awareness of Infection and Medical Follow-Up Among persons Testing Positive for Hepatitis C Virus — National Health and Nutrition Examination Survey, 2001‒2014
Monique Foster, MD, MPH ; Laurie Barker, MSPH ; Ruth Jiles, PhD, MPH, MS ; Scott Holmberg, MD, MPH, FIDSA
11:09 AM
1788
Paritaprevir/ritonavir, Ombitasvir, Dasabuvir Combination and the Rate and Risk of Hepatic Decompensation: Results from ERCHIVES
Adeel Butt, MD, MS ; Yanjie Ren, MS ; Kristen M. Marks, MD ; Obaid Shaikh, MD ; Kenneth E. Sherman, MD
11:22 AM
1789
Lipid Levels and the Risk of Acute Myocardial Infarction Among HCV Infected and Uninfected Persons: Results from ERCHIVES
Adeel Butt, MD, MS ; Peng Yan, MS ; Kara Chew, MD, MS ; Judith Currier, MD, MSc, MPH, FIDSA ; Kathleen Corey, MD ; Raymond T. Chung, MD ; Javed Butler, MD, MPH ; Matthew Freiberg, MD, MSc
11:35 AM
1790
Building Oregon Data: Short-term Incidence of Sequelae of Chronic Liver Disease in Medicaid Patients Infected with HCV
Kazuaki Jindai, MD, MPH ; Courtney Crawford, MPH ; Daniel Hartung, Pharm D, MPH ; Atif Zaman, MD, MPH ; Ann Thomas, MD, MPH
11:48 AM
1791
Implementation of a Hepatitis C Antimicrobial Stewardship Program
Katherine Pleasants, PharmD ; Gordana Milosevic, PharmD ; Stephanie Thrall, PharmD

CME Credits: No CME credit is offered for this session.

ACPE Credits:

ACPE Number:


See more of: Oral Abstract Session
<< Previous Session | Next Session >>

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.